Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Am J Obstet Gynecol. 2019 May 25;221(4):347.e1–347.e13. doi: 10.1016/j.ajog.2019.05.034

Table 2.

Time-varying characteristics stratified by HIV status and miscarriage, WIHS 1994-2017

All women (N = 848) Women living with HIV (N =
468)
Women without HIV (N =
380)
Mis
carriage
(n=250,
29%)
Live birth
(n=598,
71%)
p-value Mis
carriage
(n=140,
30%)
Live birth
(n=328,
70%)
p-value Mis
carriage
(n=110,
29%)
Live
birth
(n=270,
71%)
p-value
n % n % n % n % n % n %
Variables (previous visit)
Age group <25 63 25 97 16 0.011 29 21 38 12 0.062 34 31 59 22 0.138
25-30 50 20 155 26 29 21 90 27 21 19 65 24
30-35 65 26 189 32 41 29 105 32 24 22 84 31
>35 72 29 157 26 41 29 95 29 31 28 62 23
Alcohol use Abstain 118 49 450 81 <.0001 76 56 263 84 <.0001 42 40 187 77 <.0001
Drinkers 123 51 108 19 60 44 51 16 63 60 57 23
Alcohol use frequency Abstain 118 49 450 81 <.0001 76 56 263 84 <.0001 42 40 187 77 <.0001
0-7 101 42 89 16 46 34 45 14 55 52 44 18
>7 22 9 19 3 14 10 6 2 8 8 13 5
Marijuana use No 171 70 492 88 <.0001 105 77 288 91 <.0001 66 62 204 83 <.0001
Yes 72 30 68 12 32 23 27 9 40 38 41 17
Marijuana use frequency None 171 71 492 88 <.0001 105 77 288 91 0.001 66 64 204 84 0.001
Less than weekly 15 6 24 4 6 4 11 3 9 9 13 5
1-6 times/week 22 9 16 3 12 9 7 2 10 10 9 4
At least daily 32 13 27 5 14 10 9 3 18 17 18 7
Cigarette smoking No 120 49 401 72 <.0001 65 47 231 73 <.0001 55 52 170 69 0.003
Yes 123 51 159 28 72 53 84 27 51 48 75 31
Health related* No 193 77 477 80 0.414 108 77 256 78 0.829 85 77 221 82 0.334
Yes 57 23 121 20 32 23 72 22 25 23 49 18
Pregnancy year 1994-1997 50 20 86 14 0.066 36 26 49 15 0.023 14 13 37 14 0.655
1998-2001 46 18 85 14 29 21 57 18 17 16 28 10
2002-5 74 30 215 36 39 28 124 38 35 32 91 34
≥2006 79 32 208 35 36 26 95 29 43 39 113 42
Any STI diagnosis** No 211 86 493 88 0.564 114 83 265 84 0.688 97 92 228 93 0.608
Yes 33 14 67 12 24 17 50 16 9 8 17 7
Yeast infection No 200 82 434 78 0.120 111 81 237 75 0.177 89 84 197 80 0.509
Yes 43 18 126 23 26 19 78 25 17 16 48 20
BV infection No 186 80 356 85 0.134 97 73 192 81 0.066 89 90 164 90 0.873
Yes 46 20 63 15 36 27 44 19 10 10 19 10
LEEP procedure No 248 99 596 100 0.389 138 99 327 100 0.208 110 100 269 100 n/a
Yes 2 1 2 0 2 1 1 0 0 0 1 0
HIV viral load ≥4 log10 copies/mL 45 33 43 14 <.0001
<4 log10 copies/mL 90 67 266 86
CD4 count <500 cells/μL No 57 43 127 41 0.759
Yes 77 57 183 59
cART regimen II, NRTI, NNRTI 23 17 71 22 <.0001
PI 28 20 128 40
No cART 87 63 121 38
AIDS defining illness No 98 70 247 75 0.235
Yes 42 30 81 25

WIHS: Women's Interagency HIV Study; cART: combination highly active antiretroviral therapy; II: integrase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitors; NRTI: nucleoside reverse transcriptase inhibitors; PI: protease inhibitor; STI: sexually transmitted infection; BV: bacterial vaginosis; LEEP: loop electrosurgical excision procedure

*

Includes stroke, cancer, myocardial infarction, high blood pressure pulmonary embolism, diabetes

**

Includes gonorrhea, trichomonas, herpes-2, genital warts, syphilis, chlamydia

‘n’ is given over all study intervals

p-values are two-tailed